Cargando…

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences

Breast cancer, a heterogeneous disease with variable pathophysiology and biology, is classified into four major subtypes. While hormonal- and antibody-targeted therapies are effective in the patients with luminal and HER-2 subtypes, the patients with triple-negative breast cancer (TNBC) subtype do n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tayyari, Fariba, Gowda, G.A. Nagana, Olopade, Olufunmilayo F., Berg, Richard, Yang, Howard H., Lee, Maxwell P., Ngwa, Wilfred F., Mittal, Suresh K., Raftery, Daniel, Mohammed, Sulma I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837744/ https://www.ncbi.nlm.nih.gov/pubmed/29545929 http://dx.doi.org/10.18632/oncotarget.24433

Ejemplares similares

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis, Odalys, et al.
Publicado: (2018)

A new limit for blood metabolite analysis using (1)H NMR spectroscopy
por: Nagana Gowda, G.A., et al.
Publicado: (2022)

Quantitating Metabolites in Protein Precipitated Serum Using NMR Spectroscopy
por: Gowda, G. A. Nagana, et al.
Publicado: (2014)

Expanding the Limits of Human Blood Metabolite Quantitation Using NMR Spectroscopy
por: Nagana Gowda, G. A., et al.
Publicado: (2014)

A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines
por: Nagana Gowda, G. A., et al.
Publicado: (2018)

Combining Hydrophilic Interaction Chromatography (HILIC) and Isotope Tagging for Off-Line LC-NMR Applications in Metabolite Analysis
por: Appiah-Amponsah, Emmanuel, et al.
Publicado: (2013)

A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD(+) Metabolome in Healthy Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled, Cross-Over Pilot Clinical Trial
por: Xue, Yongquan, et al.
Publicado: (2022)

Continuous in vivo Metabolism by NMR
por: Judge, Michael T., et al.
Publicado: (2019)

Targeting NAD(+) Metabolism as Interventions for Mitochondrial Disease
por: Lee, Chi Fung, et al.
Publicado: (2019)

Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
por: Ioannou, George N., et al.
Publicado: (2020)

Hydrogen–Deuterium Addition and Exchange in N-Ethylmaleimide Reaction with Glutathione Detected by NMR Spectroscopy
por: Nagana Gowda, G. A., et al.
Publicado: (2022)

Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
por: Lukey, Michael J., et al.
Publicado: (2019)

Simultaneous Analysis of Major Coenzymes of Cellular Redox Reactions and Energy Using ex Vivo (1)H NMR Spectroscopy
por: Nagana Gowda, G. A., et al.
Publicado: (2016)

Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling
por: Wei, Siwei, et al.
Publicado: (2012)

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
por: Xu, Jinhua, et al.
Publicado: (2015)

Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods
por: Zhang, Jian, et al.
Publicado: (2012)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Profiling Redox and Energy Coenzymes in Whole Blood, Tissue and Cells Using NMR Spectroscopy
por: Gowda, G. A. Nagana
Publicado: (2018)

Cancer progression by reprogrammed BCAA metabolism in myeloid leukemia
por: Hattori, Ayuna, et al.
Publicado: (2017)

Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2018)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Composite Analysis of Immunological and Metabolic Markers Defines Novel Subtypes of Triple Negative Breast Cancer
por: Adams, Thomas A., et al.
Publicado: (2017)

Identification of a Novel Luminal Molecular Subtype of Breast Cancer
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2014)

Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures
por: Roshanzamir, Fariba, et al.
Publicado: (2022)

Breast cancer among African American and sub-Saharan African women: a tale of global inequities
por: Gutnik, Lily, et al.
Publicado: (2022)

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017)

AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells
por: Li, Songbin, et al.
Publicado: (2022)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Doing better and being better in breast cancer care: an interview with Funmi Olopade
por: Olopade, Olufunmilayo I.
Publicado: (2021)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
por: Tiwari, Payal, et al.
Publicado: (2019)

Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes
por: Saeui, Christopher T., et al.
Publicado: (2018)

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells
por: Valla, Sofía, et al.
Publicado: (2021)

Alternatives to Nuclear Overhauser Enhancement Spectroscopy Presat and Carr–Purcell–Meiboom–Gill Presat for NMR-Based Metabolomics
por: Le Guennec, Adrien, et al.
Publicado: (2017)

Illuminating luminal B: QSOX1 as a subtype-specific biomarker
por: Das, Padmalaya, et al.
Publicado: (2013)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
por: Menikdiwela, Kalhara R., et al.
Publicado: (2022)

Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer
por: Hardeman, Ashley A., et al.
Publicado: (2022)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_un32k4c415242tt98lao302qhg